Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?
<p dir="ltr">Phosphoglycerate kinase 1 (PGK-1) is a glycolytic enzyme encoded by PGK-1, which maps to the X chromosome. PGK-1 deficiency causes X-linked recessive hereditary chronic hemolytic anemia, myopathy, and neurological disorders due to insufficient ATP regeneration. Early-ons...
محفوظ في:
| المؤلف الرئيسي: | Satoshi Sakaue (19725322) (author) |
|---|---|
| مؤلفون آخرون: | Takashi Kasai (718121) (author), Ikuko Mizuta (6578597) (author), Masaya Suematsu (12006506) (author), Shinya Osone (769429) (author), Yumiko Azuma (318823) (author), Toshihiko Imamura (769424) (author), Takahiko Tokuda (105837) (author), Hitoshi Kanno (5439200) (author), Omar M. A. El-Agnaf (8809331) (author), Masafumi Morimoto (4633492) (author), Masanori Nakagawa (105840) (author), Hajime Hosoi (259258) (author), Toshiki Mizuno (105838) (author) |
| منشور في: |
2017
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Gene-Based Therapeutics for Parkinson’s Disease
حسب: Karim E. Shalaby (12267224)
منشور في: (2022) -
The effect of Dopamine Agonists on patients with advanced Parkinson's disease subjected to subthalamic deep brain stimulation. (c2000)
حسب: Jabre, Mazen Gerges
منشور في: (2000) -
The Role of Neural Network for the Detection of Parkinson’s Disease: A Scoping Review
حسب: Mahmood Saleh Alzubaidi (18456723)
منشور في: (2021) -
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
حسب: Nour K. Majbour (8809316)
منشور في: (2016) -
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
حسب: Abolaji Samson Olagunju (16855185)
منشور في: (2023)